Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer.
|
J Biomed Opt
|
2007
|
3.04
|
2
|
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.
|
Nat Rev Microbiol
|
2008
|
3.01
|
3
|
Current advances and future challenges in Adenoviral vector biology and targeting.
|
Curr Gene Ther
|
2007
|
1.94
|
4
|
Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses.
|
Mol Ther
|
2005
|
1.86
|
5
|
Protection of the coronary arteries during epicardial radiofrequency ablation with intracoronary chilled saline irrigation: assessment in an in vitro model.
|
J Cardiovasc Electrophysiol
|
2006
|
1.70
|
6
|
Characterization of species C human adenovirus serotype 6 (Ad6).
|
Virology
|
2011
|
1.59
|
7
|
Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus.
|
Cancer Res
|
2008
|
1.57
|
8
|
Lentiviral vectors: basic to translational.
|
Biochem J
|
2012
|
1.49
|
9
|
Advances and future challenges in adenoviral vector pharmacology and targeting.
|
Curr Gene Ther
|
2011
|
1.42
|
10
|
Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification.
|
Mol Ther
|
2003
|
1.33
|
11
|
Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression.
|
Mol Ther
|
2008
|
1.28
|
12
|
Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines.
|
PLoS One
|
2009
|
1.26
|
13
|
Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector.
|
Mol Ther
|
2004
|
1.26
|
14
|
Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents.
|
Virology
|
2009
|
1.23
|
15
|
Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus.
|
Hum Gene Ther
|
2009
|
1.21
|
16
|
Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo.
|
J Virol
|
2009
|
1.18
|
17
|
Bipolar ablation of the interventricular septum is more efficient at creating a transmural line than sequential unipolar ablation.
|
Pacing Clin Electrophysiol
|
2010
|
1.15
|
18
|
Expanded anticancer therapeutic window of hexon-modified oncolytic adenovirus.
|
Mol Ther
|
2009
|
1.15
|
19
|
Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda Red recombination.
|
Hum Gene Ther
|
2004
|
1.15
|
20
|
Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari.
|
J Virol
|
2010
|
1.13
|
21
|
Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting.
|
Virology
|
2006
|
1.11
|
22
|
Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors.
|
J Virol
|
2011
|
1.09
|
23
|
Cryoelectron microscopy of protein IX-modified adenoviruses suggests a new position for the C terminus of protein IX.
|
J Virol
|
2006
|
1.09
|
24
|
Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia.
|
Hum Gene Ther
|
2007
|
1.08
|
25
|
Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules.
|
Vaccine
|
2007
|
1.08
|
26
|
A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1.
|
Proc Natl Acad Sci U S A
|
2004
|
1.08
|
27
|
Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses.
|
Hum Gene Ther
|
2008
|
1.01
|
28
|
Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines.
|
Viruses
|
2009
|
1.01
|
29
|
In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model.
|
Hum Gene Ther
|
2003
|
1.01
|
30
|
Infection and killing of multiple myeloma by adenoviruses.
|
Hum Gene Ther
|
2010
|
0.98
|
31
|
In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels.
|
J Control Release
|
2005
|
0.97
|
32
|
The role of T cell antagonism and original antigenic sin in genetic immunization.
|
J Immunol
|
2002
|
0.96
|
33
|
Evaluation of bone regeneration by DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in a critical-sized calvarial defect.
|
J Biomed Mater Res A
|
2006
|
0.95
|
34
|
Characterization of DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in vitro.
|
J Biomed Mater Res A
|
2006
|
0.95
|
35
|
Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer.
|
Mol Ther
|
2011
|
0.95
|
36
|
Targeting adenoviruses with factor x-single-chain antibody fusion proteins.
|
Hum Gene Ther
|
2010
|
0.95
|
37
|
Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia.
|
Hum Gene Ther
|
2011
|
0.93
|
38
|
Synthesis and conformational evaluation of a novel gene delivery vector for human mesenchymal stem cells.
|
Biomacromolecules
|
2008
|
0.92
|
39
|
Deoxyribonuclease II is a lysosomal barrier to transfection.
|
Mol Ther
|
2003
|
0.91
|
40
|
Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy.
|
Dis Model Mech
|
2013
|
0.91
|
41
|
Maximizing antigen targeting to the proteasome for gene-based vaccines.
|
Mol Ther
|
2004
|
0.90
|
42
|
Circulating antibodies and macrophages as modulators of adenovirus pharmacology.
|
J Virol
|
2013
|
0.90
|
43
|
A library-selected, Langerhans cell-targeting peptide enhances an immune response.
|
DNA Cell Biol
|
2004
|
0.90
|
44
|
Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targeting.
|
J Virol
|
2005
|
0.89
|
45
|
Short-term rescue of neonatal lethality in a mouse model of propionic acidemia by gene therapy.
|
Hum Gene Ther
|
2009
|
0.88
|
46
|
Intramyocardial adiposity after myocardial infarction: new implications of a substrate for ventricular tachycardia.
|
Circulation
|
2013
|
0.88
|
47
|
Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin.
|
PLoS One
|
2011
|
0.87
|
48
|
Comparison of electroanatomic contact and noncontact mapping of ventricular scar in a postinfarct ovine model with intramural needle electrode recording and histological validation.
|
Circ Arrhythm Electrophysiol
|
2008
|
0.87
|
49
|
Species D adenoviruses as oncolytics against B-cell cancers.
|
Clin Cancer Res
|
2011
|
0.86
|
50
|
Selection of chronic lymphocytic leukemia binding peptides.
|
Cancer Res
|
2003
|
0.85
|
51
|
Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice.
|
FASEB J
|
2012
|
0.83
|
52
|
Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV.
|
PLoS One
|
2013
|
0.83
|
53
|
Development and characterization of enhanced green fluorescent protein and luciferase expressing cell line for non-destructive evaluation of tissue engineering constructs.
|
Biomaterials
|
2004
|
0.83
|
54
|
Generation of a hypomorphic model of propionic acidemia amenable to gene therapy testing.
|
Mol Ther
|
2013
|
0.82
|
55
|
Real-time dynamic imaging of virus distribution in vivo.
|
PLoS One
|
2011
|
0.81
|
56
|
Increased transduction of skeletal muscle cells by fibroblast growth factor-modified adenoviral vectors.
|
Hum Gene Ther
|
2006
|
0.81
|
57
|
Low seroprevalent species D adenovirus vectors as influenza vaccines.
|
PLoS One
|
2013
|
0.81
|
58
|
A vector-host system to fingerprint virus tropism.
|
Hum Gene Ther
|
2012
|
0.81
|
59
|
Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine.
|
J Immunol
|
2002
|
0.80
|
60
|
Repertoire and immunofocusing of CD8 T cell responses generated by HIV-1 gag-pol and expression library immunization vaccines.
|
J Immunol
|
2004
|
0.80
|
61
|
Clinical evaluation of a new technique to monitor return electrode skin temperature during radiofrequency ablation.
|
J Interv Card Electrophysiol
|
2012
|
0.79
|
62
|
Improved transduction of human corneal epithelial progenitor cells with cell-targeting adenoviral vectors.
|
Exp Eye Res
|
2006
|
0.79
|
63
|
Rad23 as a reciprocal agent for stimulating or repressing immune responses.
|
Hum Gene Ther
|
2005
|
0.78
|
64
|
Beta cell regeneration after single-round immunological destruction in a mouse model.
|
Diabetologia
|
2014
|
0.78
|
65
|
Effects of adeno-associated virus serotype and tissue-specific expression on circulating biomarkers of propionic acidemia.
|
Hum Gene Ther
|
2014
|
0.77
|
66
|
Long-term sex-biased correction of circulating propionic acidemia disease markers by adeno-associated virus vectors.
|
Hum Gene Ther
|
2015
|
0.77
|
67
|
Activation of refractory T cell responses against hepatitis C virus core protein by ablation of interfering hydrophobic domains.
|
Mol Ther
|
2005
|
0.77
|
68
|
CD46-mediated transduction of a species D adenovirus vaccine improves mucosal vaccine efficacy.
|
Hum Gene Ther
|
2014
|
0.77
|
69
|
Early osteoblastic differentiation induced by dexamethasone enhances adenoviral gene delivery to marrow stromal cells.
|
J Orthop Res
|
2004
|
0.77
|
70
|
Comparison of adenoviruses as oncolytics and cancer vaccines in an immunocompetent B cell lymphoma model.
|
Hum Gene Ther
|
2011
|
0.76
|
71
|
Revised non-contact mapping of ventricular scar in a post-infarct ovine model with validation using contact mapping and histology.
|
Europace
|
2010
|
0.75
|
72
|
Bone regeneration through transplantation of genetically modified cells.
|
Clin Plast Surg
|
2003
|
0.75
|
73
|
Evaluation of noncontact mapping by comparison with simultaneous multisite contact recordings in acute ischemic ventricular fibrillation.
|
J Cardiovasc Electrophysiol
|
2010
|
0.75
|
74
|
Simultaneous biventricular noncontact mapping and ablation of septal ventricular tachycardia in a chronic ovine infarct model.
|
Circ Arrhythm Electrophysiol
|
2009
|
0.75
|
75
|
Common cold, uncommon variation.
|
N Engl J Med
|
2009
|
0.75
|
76
|
Advancing aspirin utilization: a review of clinical and systems-based interventions.
|
Am J Med Qual
|
2010
|
0.75
|
77
|
Transcatheter non-contact microwave ablation may enable circumferential renal artery denervation while sparing the vessel intima and media.
|
EuroIntervention
|
2016
|
0.75
|
78
|
Percutaneous microwave ablation with a long side-firing antenna array can successfully treat a nonsurgical chronic ovine atrial flutter model.
|
J Cardiovasc Electrophysiol
|
2009
|
0.75
|
79
|
Electrical impedance tomography for assessing ventilation/perfusion mismatch for pulmonary embolism detection without interruptions in respiration.
|
Conf Proc IEEE Eng Med Biol Soc
|
2014
|
0.75
|
80
|
Generation of multivalent genome-wide T cell responses in HLA-A*0201 transgenic mice by an HIV-1 expression library immunization (ELI) vaccine.
|
Res Initiat Treat Action
|
2003
|
0.75
|
81
|
Targeted delivery of expression plasmids to the lung via macroaggregated polyethylenimine-albumin conjugates.
|
Methods Mol Med
|
2003
|
0.75
|